These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Advances and Obstacles in the Genetic Dissection of Chlamydial Virulence. Brothwell JA; Muramatsu MK; Zhong G; Nelson DE Curr Top Microbiol Immunol; 2018; 412():133-158. PubMed ID: 29090367 [TBL] [Abstract][Full Text] [Related]
25. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Murthy AK; Cong Y; Murphey C; Guentzel MN; Forsthuber TG; Zhong G; Arulanandam BP Infect Immun; 2006 Dec; 74(12):6722-9. PubMed ID: 17015458 [TBL] [Abstract][Full Text] [Related]
26. Chlamydial heat shock protein 60 and lipopolysaccharide: potential virulence determinants in atherogenesis. Kalayoglu MV Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):249-55. PubMed ID: 14561189 [TBL] [Abstract][Full Text] [Related]
27. The Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin and prevents microtubule assembly. Archuleta TL; Du Y; English CA; Lory S; Lesser C; Ohi MD; Ohi R; Spiller BW J Biol Chem; 2011 Sep; 286(39):33992-8. PubMed ID: 21841198 [TBL] [Abstract][Full Text] [Related]
28. Chlamydial infection induces host cytokinesis failure at abscission. Brown HM; Knowlton AE; Grieshaber SS Cell Microbiol; 2012 Oct; 14(10):1554-67. PubMed ID: 22646503 [TBL] [Abstract][Full Text] [Related]
29. Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal. Betts HJ; Wolf K; Fields KA Curr Opin Microbiol; 2009 Feb; 12(1):81-7. PubMed ID: 19138553 [TBL] [Abstract][Full Text] [Related]
30. The chlamydial protease CPAF: important or not, important for what? Häcker G Microbes Infect; 2014 May; 16(5):367-70. PubMed ID: 24607702 [TBL] [Abstract][Full Text] [Related]
32. Insights into the Autoproteolytic Processing and Catalytic Mechanism of the Dudiak BM; Maksimchuk KR; Bednar MM; Podracky CJ; Burg JM; Nguyen TM; Nwogbo FO; Valdivia RH; McCafferty DG Biochemistry; 2019 Aug; 58(33):3527-3536. PubMed ID: 31386347 [TBL] [Abstract][Full Text] [Related]
33. The role of an enzymatically inactive CPAF mutant vaccination in Chlamydia muridarum genital tract infection. Chen H; Peng B; Yang C; Xie L; Zhong S; Sun Z; Li Z; Wang C; Liu X; Tang X; Zhong G; Lu C Microb Pathog; 2021 Nov; 160():105137. PubMed ID: 34390765 [TBL] [Abstract][Full Text] [Related]
34. Chlamydia protease-like activity factor (CPAF): characterization of proteolysis activity in vitro and development of a nanomolar affinity CPAF zymogen-derived inhibitor. Bednar MM; Jorgensen I; Valdivia RH; McCafferty DG Biochemistry; 2011 Sep; 50(35):7441-3. PubMed ID: 21830778 [TBL] [Abstract][Full Text] [Related]
35. The Waddlia genome: a window into chlamydial biology. Bertelli C; Collyn F; Croxatto A; Rückert C; Polkinghorne A; Kebbi-Beghdadi C; Goesmann A; Vaughan L; Greub G PLoS One; 2010 May; 5(5):e10890. PubMed ID: 20531937 [TBL] [Abstract][Full Text] [Related]
37. Type III secretion à la Chlamydia. Peters J; Wilson DP; Myers G; Timms P; Bavoil PM Trends Microbiol; 2007 Jun; 15(6):241-51. PubMed ID: 17482820 [TBL] [Abstract][Full Text] [Related]
38. Induction and inhibition of CPAF activity during analysis of Chlamydia-infected cells. Johnson KA; Lee JK; Chen AL; Tan M; Sütterlin C Pathog Dis; 2015 Feb; 73(1):1-8. PubMed ID: 25663342 [TBL] [Abstract][Full Text] [Related]
39. A working model for the type III secretion mechanism in Chlamydia. Ferrell JC; Fields KA Microbes Infect; 2016 Feb; 18(2):84-92. PubMed ID: 26515030 [TBL] [Abstract][Full Text] [Related]
40. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Dong F; Su H; Huang Y; Zhong Y; Zhong G Infect Immun; 2004 Jul; 72(7):3863-8. PubMed ID: 15213128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]